Law firms and lobby shops in Washington, D.C., are seeing an influx of business from health care and pharmaceutical clients, leading to a series of new hires and revolving door spins as firms bulk up their health care policy groups.

Appropriation bills, Food and Drug Administration discussions over so-called user fee agreements and legislation on health care preparedness are all driving business now.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]